CXDO vs. ATEX, GTN, SPIR, WOW, AREN, IHRT, SSP, TSQ, CRGE, and VOCL
Should you be buying Crexendo stock or one of its competitors? The main competitors of Crexendo include Anterix (ATEX), Gray Media (GTN), Spire Global (SPIR), WideOpenWest (WOW), The Arena Group (AREN), iHeartMedia (IHRT), E.W. Scripps (SSP), Townsquare Media (TSQ), Charge Enterprises (CRGE), and Creatd (VOCL). These companies are all part of the "communication" industry.
Crexendo vs. Its Competitors
Crexendo (NASDAQ:CXDO) and Anterix (NASDAQ:ATEX) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings.
Crexendo has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Anterix has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.
In the previous week, Crexendo had 17 more articles in the media than Anterix. MarketBeat recorded 19 mentions for Crexendo and 2 mentions for Anterix. Anterix's average media sentiment score of 1.44 beat Crexendo's score of 0.36 indicating that Anterix is being referred to more favorably in the news media.
Crexendo has higher revenue and earnings than Anterix. Anterix is trading at a lower price-to-earnings ratio than Crexendo, indicating that it is currently the more affordable of the two stocks.
Crexendo has a net margin of 3.86% compared to Anterix's net margin of -188.56%. Crexendo's return on equity of 10.55% beat Anterix's return on equity.
9.5% of Crexendo shares are owned by institutional investors. Comparatively, 87.7% of Anterix shares are owned by institutional investors. 56.2% of Crexendo shares are owned by company insiders. Comparatively, 45.6% of Anterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Crexendo presently has a consensus price target of $8.38, suggesting a potential upside of 31.06%. Anterix has a consensus price target of $67.00, suggesting a potential upside of 173.92%. Given Anterix's stronger consensus rating and higher possible upside, analysts plainly believe Anterix is more favorable than Crexendo.
Summary
Crexendo beats Anterix on 11 of the 17 factors compared between the two stocks.
Get Crexendo News Delivered to You Automatically
Sign up to receive the latest news and ratings for CXDO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CXDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crexendo Competitors List
Related Companies and Tools
This page (NASDAQ:CXDO) was last updated on 7/8/2025 by MarketBeat.com Staff
